Multiple sclerosis (MS) is an inflammatory and demyelinating disorder of the central nervous system affecting 2.3 million people worldwide. Myelin is a sheath around nerves that aids in conducting nerve impulses. Demyelination is a breakdown of this sheath. It is not reversible naturally or through existing drugs. As MS progresses, it affects muscles, nerves, and joints, causing significant pain, as well as spasms, stiffness, tremors, body mobility limitations and weakness, difficulty chewing, swallowing, and speaking.
Currently, there are several approved drugs on the market for MS, all of which are primarily for the relief of symptoms and none are disease-modifying or curative.